Evidence map›Paper›PMID 42281521›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2026

Machine Learning-Optimized Single-Atom Catalysts Enable Microenvironment-Adaptive Chemodynamic-Bioorthogonal Cancer Therapy.

Xiangxuan Chao, Zitong Zhao, Chengming Du, Xiaozhen Zhou, Chenyao Wu, Wei Feng, Lili Xia, Yu Chen

Abstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiangxuan ChaoMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai, China.
Zitong ZhaoMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai, China.
Chengming DuMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai, China.
Xiaozhen ZhouMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai, China.
Chenyao WuMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai, China.ORCID https://orcid.org/0000-0002-5179-5064
Wei FengMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai, China.ORCID https://orcid.org/0000-0002-8304-2737
Lili XiaMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai, China.
Yu ChenMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai, China.ORCID https://orcid.org/0000-0002-8206-3325

Funding

China Postdoctoral Science Foundation 2024M751935China Postdoctoral Science Foundation 2024M751936Foundation of Shanghai Key Laboratory of Thoracic Tumor Biotherapy 2025SZ1005Foundation of State Key Laboratory of Advanced Fiber Materials KF2404National Natural Science Foundation of China 52272279National Natural Science Foundation of China 52402349National Natural Science Foundation of China 82502550Postdoctoral Fellowship Program of CPSF GZC20231525Postdoctoral Fellowship Program of CPSF GZC20231530Shanghai Science and Technology Committee Biomedical Program 23S11900900
6 · The paper itself

Abstract

Chemodynamic therapy (CDT), which harnesses endogenous chemical energy within the tumor microenvironment (TME), has shown high potential for precise cancer treatment. However, its efficacy is often limited by the mildly acidic and reductive nature of the TME that compromises catalyst stability and activity. Developing catalysts capable of maintaining robust performance under such physiological constraints remains a key challenge. Herein, we report a programmable dual-catalytic platform that integrates machine learning-guided design with atomic-level precision. Through predictive modeling, we establish quantitative structure-performance relationships that guided the rational synthesis of iron single-atoms (Fe-N

Indexed as

Antineoplastic AgentsIronMachine LearningNeoplasmsTumor MicroenvironmentAnimalsCatalysisCell Line, TumorDoxorubicinHumansHydrogen PeroxideProdrugsAntineoplastic AgentsDoxorubicinHydrogen PeroxideIronProdrugsbioorthogonal chemistrychemodynamic catalysismachine learningsingle atom catalystsynergy therapy

Identifiers

PMID42281521
PMCPMC13378213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.